Acne Drug's hidden toll on the eye revealed

NCT ID NCT07675460

Completed Knowledge-focused Sponsor: Demet Mutlu Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study looks at how isotretinoin, a vitamin A-based acne medication, affects eye structures and tear production in people with severe cystic acne. Participants receive standard treatment and undergo eye exams, including dry eye tests and advanced imaging, before and during therapy. The goal is to catch potential eye side effects early by comparing those just starting treatment with those who have completed six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: isotretinoin (vitamin A derivative)
What this could lead to: If successful, this could help doctors detect and prevent eye-related side effects early in people taking isotretinoin for severe acne.
What could go wrong: This is a small, early-stage observational study, not a treatment trial. It may not lead to changes in clinical practice, and the eye changes measured may not predict real-world harm.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE CYSTIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acne dry eye syndrome retinal vascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACNE CYSTIC CHOROIDAL THICKNESS DRY EYE ISOTRETINOIN RETINAL VASCULARISATION

Contacts and locations

Locations

Kayseri City Hospital

Kayseri, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.